$UTMD 8-K SEC Filings

Filed On	Filing
22 Oct 2026	8-K: Results of Operations and Financial Condition Salt Lake City, Utah – Utah Medical Products, Inc. [Nasdaq: UTMD] reports third quarter (3Q) and first nine months (9M) of calendar year 2026 financial results that include changes from the prior year’s same period results.
31 Aug 2026	8-K: Regulation FD Disclosure
23 Jul 2026	8-K: Results of Operations and Financial Condition
04 May 2026	8-K: Submission of Matters to a Vote of Security Holders
23 Apr 2026	8-K: Results of Operations and Financial Condition
29 Jan 2026	8-K: Results of Operations and Financial Condition
04 Nov 2025	8-K: Departure/Election of Directors or Officers; Compensation; Other Events
23 Oct 2025	8-K: Results of Operations and Financial Condition
24 Jul 2025	8-K: Results of Operations and Financial Condition
05 May 2025	8-K: Submission of Matters to a Vote of Security Holders
29 Apr 2025	8-K: Results of Operations and Financial Condition
28 Jan 2025	8-K: Results of Operations and Financial Condition
05 Nov 2024	8-K: Departure/Election of Directors or Officers; Compensation; Other Events
29 Oct 2024	8-K: Results of Operations and Financial Condition
25 Jul 2024	8-K: Completion of Acquisition or Disposition of Assets
06 May 2024	8-K: Submission of Matters to a Vote of Security Holders
25 Apr 2024	8-K: Completion of Acquisition or Disposition of Assets
30 Jan 2024	8-K: Results of Operations and Financial Condition
31 Oct 2023	8-K: Other Events
26 Oct 2023	8-K: Results of Operations and Financial Condition

Comments